GlassScriptPhysician profile
Ricaurte Antonio Solis
NPI 1295996924
$1,032.30
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $203 · 2021: $110 · 2022: $109 · 2023: $230 · 2024: $41.30 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $458.53 | 2021-2024 | Na Electrode,Indirect,International, Patient Monitor |
| Haemonetics Corporation | $147.73 | 2025 | Teg6s Hemostasis System |
| Pfizer INC. | $122.06 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $121.74 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $105.83 | 2020 | |
| Csl Behring | $37.38 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $27.68 | 2020 | |
| Melinta Therapeutics, LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricaurte Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.